Agreement deploys patented nano-polishing technology inside one of medtech's fastest-growing markets

Planatome LLC, developer of a proprietary nano-polishing technology, today announced a commercial agreement with a major undisclosed U.S. supplier of robotic-assisted and minimally invasive surgical (RAS/MIS) tools. The first phase is live: Under the terms of the agreement, Planatome is nano-polishing the supplier's devices at its Phoenix facility. The second phase, comprising full integration of the technology into the supplier's manufacturing line, is scheduled for 2027.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.